bmiMD vs Novi: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
bmiMD beats Novi overall, scoring 8/10 vs 7.8/10. Novi is more affordable at $133/mo vs $319/mo. Choose bmiMD for budget-first users who want affordable glp-1 access. Choose Novi for cash-pay patients who want compounded semaglutide or tirzepa.
A side-by-side comparison of bmiMD and Novi covering pricing, scores, medication types, insurance, and more to help you decide.
bmiMD
#9 of 46Budget-friendly GLP-1 platform offering both medication types at one of the lowest price points in the market.
Visit bmiMDNovi
#14 of 46Telehealth platform for compounded semaglutide and tirzepatide with month-to-month billing, six named clinicians on staff, and a 3-minute pre-approval quiz. Novi emphasizes 'all-in transparent' pricing — medication, supplies, unlimited clinician check-ins, dose adjustments, and weight-loss coaching are bundled with no add-on fees. Standard pricing is $174/mo semaglutide and $283/mo tirzepatide; promotional pricing on the offer landing drops to $99-$133/mo semaglutide and $149-$166/mo tirzepatide with $200 off advertised.
Visit Novi| Feature | bmiMD | Novi |
|---|---|---|
| Our Score | 8/10 | 7.8/10 |
| Starting Price | $319/mo | $133/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | Budget-first users who want affordable GLP-1 access | Cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer |
| Ranking | #9 | #14 |
Pros & Cons Compared
bmiMD
Pros
- +Same-day physician consults — one of the few platforms offering telehealth appointments the same day you apply
- +80,000+ customer base with 4.9-star Trustpilot rating provides strong social proof of reliability
- +100% money-back guarantee if your consultation determines you don't qualify for GLP-1 treatment
- +HSA/FSA accepted for all programs
Cons
- −Starting at $289/mo for semaglutide — significantly more expensive than competitors at $99-199/mo
- −$29.99 shipping fee per order — most competitors include free shipping
- −$50 non-refundable cancellation fee after intake approval — penalizes patients who change their mind
Novi
Pros
- +Six disclosed clinicians on staff — Daniel Funsch MD, Michael Wasef MD, Takashi Nakamura MD plus three nurse practitioners (Hastings NP, Clements NP, Vergara DNP) — more named providers than most compounded-only platforms publish
- +Month-to-month billing with no minimum commitment — cancel before any renewal date with no early-termination penalty
- +Aggressive promotional pricing on the offer landing — $99-$133/mo compounded semaglutide and $149-$166/mo compounded tirzepatide with a $200 OFF intro discount
- +Unlimited clinician check-ins, dose adjustments, and weight-loss coaching included at no additional cost
- +Free 2-day shipping; same active ingredients as Wegovy/Ozempic and Mounjaro/Zepbound (semaglutide and tirzepatide respectively)
- +100,000+ patients claimed and editorial coverage in Bloomberg, Forbes, and WebMD provide third-party signal
Cons
- −Compounded-only — no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro through the platform; no Foundayo or oral GLP-1 formats
- −Founding year, headquarters city, and corporate ownership are not publicly disclosed
- −Promotional $99-$133 pricing applies to the introductory offer landing only — standard rate after any qualifying intro period is $174-$283/mo (verify the renewal rate before enrolling)
- −Once medication is dispensed/shipped, prescriptions cannot be returned or refunded — typical for compounded telehealth but worth understanding
- −Lab requirements before prescribing are not disclosed on public pages — unclear whether baseline bloodwork is required
- −Multiple landing pages (offer-v4, offer-v6-low) show different headline prices, which can create pricing confusion before checkout
Our Verdict
bmiMD edges out Novi with a score of 8/10 vs 7.8/10. If budget is your priority, Novi starts at $133/mo compared to bmiMD's $319/mo. bmiMD offers both brand-name and compounded medications, giving you more flexibility. Choose bmiMD if you want: budget-first users who want affordable glp-1 access. Choose Novi if you want: cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer.